|本期目录/Table of Contents|

转录因子E2F1对急性单核细胞白血病新抗原基因MLAA-34的转录调控作用

《现代肿瘤医学》[ISSN:1672-4992/CN:61-1415/R]

期数:
2019年20期
页码:
3560-3565
栏目:
论着(基础研究)
出版日期:
2019-09-08

文章信息/Info

Title:
Effects of transcription factor E2F1 on transcriptive regulation of acute monocytic leukemia -related gene MLAA-34
作者:
雷 博;?张王刚;?何爱丽;?陈银霞;?曹星梅;?张鹏宇;?赵万红;?王剑利;?刘 捷;?马肖容;?张彦平;?刘海玲
西安交通大学第二附属医院血液科,陕西 西安 710004
Author(s):
Lei Bo;?Zhang Wanggang;?He Aili;?Chen Yinxia;?Cao Xingmei;?Zhang Pengyu;?Zhao Wanhong;?Wang Jianli;?Liu Jie;?Ma Xiaorong;?Zhang Yanping;?Liu Hailing
Department of Hematology,The Second Affiliated Hospital,Medical School of Xi'an Jiaotong University,Shaanxi Xi'an 710004,China.
关键词:
急性单核细胞白血病;?MLAA-34;?E2F1;?转录调控
Keywords:
acute monocytic leukemia;?MLAA-34;?E2F1;?transcriptional regulation
分类号:
R733.71
DOI:
10.3969/j.issn.1672-4992.2019.20.004
文献标识码:
A
qq自动领红包软件:
目的:探讨转录因子E2F1对急性单核细胞白血病新抗原基因MLAA-34的转录调控作用。方法:利用双荧光素酶报告基因检测系统及定点突变技术分析E2F1 对MLAA-34基因启动子转录活性的影响。通过凝胶迁移实验(EMSA)和染色质免疫共沉淀(ChIP)实验,验证E2F1是否与MLAA-34启动子核心区直接特异性结合。构建E2F1真核表达载体和干涉载体,转染U937细胞,RT-PCR 和Western Blot检测MLAA-34基因的转录和表达变化。结果:转录因子E2F1对MLAA-34基因表达具有调控作用,E2F1结合序列点突变后,相对荧光素酶活性升高(P<0.01),绿色荧光蛋白的表达增高。EMSA和ChIP实验,从细胞内、外水平分别证明E2F1可与MLAA-34启动子直接结合而发挥调控作用。在过表达试验中,E2F1的增加可下调MLAA-34的表达(P<0.05);在干涉试验中,E2F1的降低可上调MLAA-34的表达(P<0.05)。结论:转录因子E2F1可与MLAA-34基因启动子上的转录调控区结合,并抑制急性单核细胞白血病细胞中MLAA-34基因的转录。
Abstract:
Objective:To investigate the transcriptional regulation of transcription factor E2F1 on acute monocytic leukemia-related gene MLAA-34.Methods:The effect of E2F1 on the transcriptional activity of MLAA-34 gene promoter was analyzed by luciferase reporter gene detection system and site-directed mutation technique.EMSA and ChIP assay were used to verify whether E2F1 directly and specifically binds to the core region of MLAA-34 promoter.The over-expression vector and interference vector of E2F1 were constructed to transfect U937 cells,and RT-PCR and Western Blot were used to detect the transcription and expression changes of MLAA-34 gene.Results:The transcription factor E2F1 had a regulatory effect on MLAA-34 gene expression,and the relative luciferase activity was increased after E2F1 binding point mutation (P<0.01).EMSA and ChIP experiments demonstrated that E2F1 can directly bind to MLAA-34 promoter and play a regulatory role.In the over-expression test,the increase of E2F1 can down-regulate the expression of MLAA-34 (P<0.05).In the interference test,the decrease of E2F1 can up-regulate the expression of MLAA-34 (P<0.05).Conclusion:Transcription factor E2F1 can bind to the transcriptional regulatory region on the promoter of MLAA-34 gene and inhibit the transcription of MLAA gene in acute monocytic leukemia.

参考文献/References

[1]Estey E.Acute myeloid leukemia:2016 update on risk-stratification and management [J].Am J Hematol,2016,91(8):824-846.
[2]Chen G,Zhang W,Cao X,et al.Serological identification of immunogenic antigens in acute monocytic leukemia[J].Leuk Res,2005,29(5):503-509.
[3]Zhang PY,Zhang WG,He AL,et al.Identification and functional characterization of the novel acute monocytic leukemia associated antigen MLAA-34[J].Cancer Immunol Immunother,2009,58(2):281-290.
[4]Zhang WJ,Zhang WG,Zhang PY,et al.The expression and functional characterization associated with cell apoptosis and proteomic analysis of the novel gene MLAA-34 in U937 cells[J].Oncol Rep,2013,29(2):491-506.
[5]Zhao J,He AL,Zhang WG,et al.Quantitative assessment of MLAA-34 expression in diagnosis and prognosis of acute monocytic leukemia[J].Cancer Immunol Immunother,2011,60(4):587-597.
[6]Lei B,Chen YX,He AL,et al.C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia[J].Oncol Lett,2017,14(1):55-62.
[7]Lei B,Zhang WG,He AL,et al.Cloning of new antigen gene MLAA-34 promoter and identification of core region in acute monocytic leukemia[J].J Exp Hematol,2019,27(3):641-645.
[8]Sutton MN,Huang GY,Zhou J,et al.Amino acid deprivation-induced autophagy requires upregulation of DIRAS3 through reduction of E2F1 and E2F4 transcriptional repression [J].Cancers (Basel),2019,11(5):603.
[9]Fabre B,Livneh I,Ziv T,et al.Modulation of the cell cycle regulating transcription factor E2F1 pathway by the proteasome following amino acid starvation[J].Biochem Biophys Res Commun,2019,513(3):721-725.
[10]Meng P,Bedolla RG,Yun H,et al.Contextual role of E2F1 in suppression of melanoma cell motility and invasiveness[J].Mol Carcinog,2019:1-10.
[11]Farra R,Dapas B,Grassi M,et al.E2F1 as a molecular drug target in ovarian cancer[J].Expert Opin Ther Targets,2019,23(3):161-164.
[12]Qian L,Zhang W,Zhang P,et al.The anti-apoptosis effect of MLAA-34 in leukemia andthe β-catenin/T cell factor 4 protein pathway[J].American Journal of Translational Research,2016(7):2270-2278.
[13]Chen J,Gong C,Mao H,et al.E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells[J].Int J Oncol,2018,53(2):567-578.
[14]Song Y,Chen QT,He QQ.Identification of key transcription factors in endometrial cancer by systems bioinformatics analysis[J].J Cell Biochem,2019.doi:10.1002/jcb.28811.
[15]Zhang L,Tan W,Zhou J,et al.Investigation of G-quadruplex formation in the FGFR2 promoter region and its transcriptional regulation by liensinine[J].Biochim Biophys Acta Gen Subj,2017,1861(4):884-891.
[16]Iglesias-Ara A,Osinalde N,Zubiaga AM.Detection of E2F-induced transcriptional activity using a dual luciferase reporter assay[J].Methods Mol Biol,2018(1726):153-166.
[17]Koh KH,Jeong H.Electrophoretic mobility shift assay (EMSA) and supershift assay of cytochrome P450 2B6 in response to estrogen[J].Methods Mol Biol,2016(1366):41-51.
[18]Visa N,Jordán-Pla A.ChIP and ChIP-related techniques:Expanding the fields of application and improving ChIP performance[J].Methods Mol Biol,2018(1689):1-7.
[19]Bohaciakova D,Renzova T,Fedorova V,et al.An efficient method for generation of knockout human embryonic stem cells using CRISPR/Cas9 system[J].Stem Cells Dev,2017,26(21):1521-1527.
[20]Oh KS,Ha J,Baek S,et al.XL-DNase-seq:Improved footprinting of dynamic transcription factors[J].Epigenetics Chromatin,2019,12(1):30.

备注/Memo

备注/Memo:
National Natural Science Foundation of China(No.8153000580);国家自然科学基金资助(编号:8153000580)
更新日期/Last Update: 1900-01-01